Brief: RenovoRx Says As Of Sept 30, Co Had Cash, Cash Equivalents Of $17.7 Mln And No Outstanding Debt Obligations
15/11/2021 22:11
Nov 15 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS
* RENOVORX INC - AS OF SEPT 30, 2021, CO HAD CASH, CASH
EQUIVALENTS OF $17.7 MILLION AND NO OUTSTANDING DEBT OBLIGATIONS
Source text for Eikon: ID:nBw5vBCgma
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer